We speculate that there may be a greater role for RIPK2 utilization by peripheral immune cells, who are known to express RIPK2 [26, 51, 52], in promoting stroke injury, and that this may explain the more powerful protective effect observed in our Ripk2−/− compared to our μKO animals. The gene discussed is RIPK2; the disease is stroke disorder.